ADRs End Mostly Higher, Immutep Trades Actively
Provided by
Dow Jones
By Sabela Ojea
International stocks trading in New York closed mostly higher on Thursday.
The S&P/BNY Mellon index of American depositary receipts rose 0.2% to 148.87. The European index declined 0.4% to 146.63, the Asian index increased 1.5% to 167.67, the Latin American index fell 0.4% to 187.40 and the emerging markets index climbed 2% to 280.12.
ADRs of Immutep closed down 6.1% to $2.30 after the biotechnology company said it saw promising new clinical data in first line non-small cell lung cancer from an investigator-initiated Phase I trial conducted by the Frankfurt Institute of Clinical Cancer Research IKF.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
May 25, 2023 19:23 ET (23:23 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
Will Earnings From These 10 AI Stocks Live Up to the Hype?
-
What’s Happening In the Markets This Week
-
What the Next Bitcoin Halving Means for ETF Investors
-
Going Into Earnings, Is Microsoft a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
ServiceNow Earnings: Strong Quarter With In-Line Guidance and Increasingly Attractive Valuation
-
Ford Earnings: Pro Continues to Impress While EV Costs Are Contained
-
Boeing Earnings: Paying for Mistakes Made Long Ago, Taking Back the Factory Floor
-
Meta Earnings: Stock Now Fairly Valued After Latest Selloff
-
March PCE Inflation Index Forecasts Show Mixed Readings On Price Pressures
-
After Earnings, Is Charles Schwab Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Apple Stock a Buy, a Sell, or Fairly Valued?